Arteriovenous Fistula
Conditions
Interventions
This is a randomized, controlled, two-by-two crossover clinical trial, including thirty-four adult hemodialysis participants, randomly allocated into two groups of seventeen participants each, accordi
Sponsors
Departamento de Enfermagem
Universidade Federal do Rio Grande do Norte
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Participants of both sexes; age =18 years; undergoing hemodialysis through arteriovenous fistula puncture for at least 4 weeks and at most 4 months; functional and stable arteriovenous fistula in the last three sessions, without signs of infection; absence of neurological or cognitive conditions capable of interfering with the intervention or data collection.
Exclusion criteria
Exclusion criteria: Visual or auditory hypersensitivity; use of pharmacological therapy for anxiety or antidepressants; use of analgesics in the 24 hours prior to the procedure; history of severe migraine or balance disorders; requirement of a new puncture of the fistula during the procedure; hemodynamic instability.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It's expected to observe a change in pain intensity, assessed after arteriovenous fistula cannulation using the Visual Analogue Scale;It’s expected to observe a change in anxiety levels, assessed before and after arteriovenous fistula cannulation using the State-Trait Anxiety Inventory (STAI) | — |
Secondary
| Measure | Time frame |
|---|---|
| It’s expected to observe variation in physiological parameters, including blood pressure, heart rate, respiratory rate, and oxygen saturation, measured before and after arteriovenous fistula cannulation | — |
Countries
Brazil
Contacts
Public ContactKátia Ribeiro
Universidade Federal do Rio Grande do Norte
Outcome results
None listed